RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Go back to RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)| (NASDAQ: NMRA) | Delayed: 1.64 +0.03 (1.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.61 | 52 Week High | $ | |||
| Open | $1.60 | 52 Week Low | $ | |||
| Day High | $1.67 | P/E | N/A | |||
| Day Low | $1.60 | EPS | $ | |||
| Volume | 152,409 | |||||
